182
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Key demographic characteristics of patients with bacteriuria due to extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in a multiethnic community, in North West London

, , &
Pages 719-724 | Received 09 Jan 2015, Accepted 11 May 2015, Published online: 16 Jun 2015

References

  • Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008;8:159–66.
  • Pitout JD. Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 2010;70:313–33.
  • Livermore DM, Hawkey PM. CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother 2005;56:451–4.
  • Hawkey PM. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect 2008;14: 159–65.
  • Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 2008;13:1–11.
  • Lau SH, Kaufmann ME, Livermore DM, Woodford N, Willshaw GA, Cheasty T, et al. UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother 2008;62:1241–4.
  • Shitrit P, Reisfeld S, Paitan Y, Gottesman BS, Katzir M, Paul M, et al. Extended-spectrum beta-lactamase- producing Enterobacteriaceae carriage upon hospital admission: prevalence and risk factors. J Hosp Infect 2013; 85:230–2.
  • Soraas A, Sundsfjord A, Sandven I, Brunborg C, Jenum PA. Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae – a case-control study in a low prevalence country. PLoS One 2013;8:e69581.
  • Tangden T, Cars O, Melhus A, Löwdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010;54:3564–8.
  • Potz NA, Hope R, Warner M, Johnson AP, Livermore DM; London & South East ESBL Project Group. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England. J Antimicrob Chemother 2006;58:320–6.
  • Wickramasinghe NH, Xu L, Eustace A, Shabir S, Saluja T, Hawkey PM. High community faecal carriage rates of CTX-M ESBL-producing Escherichia coli in a specific population group in Birmingham, UK. J Antimicrob Chemother 2012;67:1108–13.
  • Andrews JM. BSAC standardized disc susceptibility testing method (version 7). J Antimicrob Chemother 2008;62: 256–78.
  • Andrews JM. BSAC standardized disc susceptibility testing method (version 6). J Antimicrob Chemother 2007;60: 20–41.
  • Andrews JM. BSAC standardized disc susceptibility testing method (version 8). J Antimicrob Chemother 2009;64: 454–89.
  • Banerjee R, Johnston B, Lohse C, Porter SB, Clabots C, Johnson JR. Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol 2013;34:361–9.
  • Mandal J, Acharya NS, Buddhapriya D, Parija SC. Antibiotic resistance pattern among common bacterial uropathogens with a special reference to ciprofloxacin resistant Escherichia coli. Indian J Med Res 2012;136:842–9.
  • Data Management and Analysis Group (DMAG) - Mayor of London Office. ONS Ethnic Group Population Estimates; Mid-2006.
  • Mathur R, Grundy E, Smeeth L. Availability and use of UK based ethnicity data for health research. National Centre for Research Methods Working Paper; 01/2013.
  • Association of Public Health Observatories. Ethnicity and Health; 2005. Available from: http://www.apho.org.uk/resource/item.aspx?RID = 39368 (accessed 25/04/2015).
  • Mathur R, Bhaskaran K, Chaturvedi N, Leon DA, vanStaa T, Grundy E, et al. Completeness and usability of ethnicity data in UK-based primary care and hospital databases. J Public Health 2014;36:684–692.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.